Ambu A/S (AMBBY)
16.12
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Ambu Price to Book Value: 5.334 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 5.334 |
| May 08, 2024 | 5.334 |
| May 07, 2024 | 5.334 |
| May 06, 2024 | 5.334 |
| May 03, 2024 | 5.334 |
| May 02, 2024 | 5.334 |
| May 01, 2024 | 5.334 |
| April 30, 2024 | 5.334 |
| April 29, 2024 | 5.320 |
| April 26, 2024 | 5.320 |
| April 25, 2024 | 5.243 |
| April 24, 2024 | 5.243 |
| April 23, 2024 | 5.243 |
| April 22, 2024 | 5.243 |
| April 19, 2024 | 5.267 |
| April 18, 2024 | 5.267 |
| April 17, 2024 | 5.267 |
| April 16, 2024 | 5.267 |
| April 15, 2024 | 5.267 |
| April 12, 2024 | 5.267 |
| April 11, 2024 | 5.595 |
| April 10, 2024 | 5.628 |
| April 09, 2024 | 5.517 |
| April 08, 2024 | 5.517 |
| April 05, 2024 | 5.517 |
| Date | Value |
|---|---|
| April 04, 2024 | 5.517 |
| April 03, 2024 | 5.517 |
| April 02, 2024 | 5.517 |
| April 01, 2024 | 5.517 |
| March 28, 2024 | 5.517 |
| March 27, 2024 | 5.517 |
| March 26, 2024 | 5.517 |
| March 25, 2024 | 5.517 |
| March 22, 2024 | 5.517 |
| March 21, 2024 | 5.517 |
| March 20, 2024 | 5.517 |
| March 19, 2024 | 5.677 |
| March 18, 2024 | 5.677 |
| March 15, 2024 | 5.784 |
| March 14, 2024 | 5.784 |
| March 13, 2024 | 5.784 |
| March 12, 2024 | 5.784 |
| March 11, 2024 | 5.784 |
| March 08, 2024 | 5.784 |
| March 07, 2024 | 5.784 |
| March 06, 2024 | 5.681 |
| March 05, 2024 | 5.760 |
| March 04, 2024 | 5.760 |
| March 01, 2024 | 5.760 |
| February 29, 2024 | 5.760 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.295
Minimum
Oct 26 2023
33.90
Maximum
Feb 05 2021
11.85
Average
10.77
Median
Oct 14 2021
Price to Book Value Benchmarks
| Genmab A/S | 3.963 |
| Ascendis Pharma A/S | -- |
| Galecto Inc | 0.6545 |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | 0.7421 |
Price to Book Value Related Metrics
| PE Ratio | 123.29 |
| PS Ratio | 5.937 |
| PEG Ratio | 1.152 |
| Price to Free Cash Flow | 59.49 |
| Price | 16.12 |
| Earnings Yield | 0.81% |
| Market Cap | 4.293B |
| PEGY Ratio | 1.152 |
| Operating PE Ratio | 80.74 |
| Normalized PE Ratio | 119.67 |